DOCSLIB.ORG

Drug-Resistant Neisseria Gonorrhoeae Threat Level Urgent

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Drug-Resistant Neisseria Gonorrhoeae Threat Level Urgent DRUG-RESISTANT NEISSERIA GONORRHOEAE THREAT LEVEL URGENT 550,000 1.14M $133.4M Estimated Total new Annual discounted drug-resistant infections lifetime direct infections each each year medical costs year Neisseria gonorrhoeae causes gonorrhea, a sexually transmitted disease (STD) that can result in life-threatening ectopic pregnancy and infertility, and can increase the risk of getting and giving HIV. WHAT YOU NEED TO KNOW EMERGING ANTIBIOTIC RESISTANCE ■ Gonorrhea has quickly developed resistance to all Gonorrhea rapidly develops resistance to antibiotics—ceftriaxone but one class of antibiotics, and half of all infections is the last recommended treatment. are resistant to at least one antibiotic. Tests to detect 35% 1980s: 2007: 2012: resistance are not available at time of treatment. Penicillin Ciprofloxacin Cefixime and tetracycline no longer no longer 30% no longer recommended recommended ■ Gonorrhea spreads easily. Some men and most women recommended as a first-line regimen do not have symptoms and may not know they are 25% infected, increasing spread. 20% ■ Untreated gonorrhea can cause serious and permanent health problems in women and men, including ectopic 15% pregnancy and infertility, and can spread to the blood resulting in cardiovascular and neurological problems. 10% Resistance or Emerging Resistance or Emerging Resistance Percent of Gonococcal Infections with Infections of Gonococcal Percent 5% 0% 2000 2002 2004 2006 2008 2010 2012 2014 2016 Azithromycin Ciprofloxacin Cefixime Penicillin Ceftriaxone Tetracycline STD Clinic Private Provider Emergency Room Family Planning Other Health Department Clinic All Other Unknown/ Missing Provider 0% 20% 40% 60% 80% 100% Percent of Patients 35% 1980s: 2007: 2012: Penicillin Ciprofloxacin Cefixime and tetracycline no longer no longer 30% no longer recommended recommended recommended as a first-line regimen 25% 20% 15% 10% Resistance or Emerging Resistance or Emerging Resistance DRUG-RESISTANT NEISSERIA GONORRHOEAE with Infections of Gonococcal Percent 5% 0% CDC RESPONSE: STD TREATMENT2000 2002 2004 2006 ACROSS2008 2010 SETTINGS2012 2014 2016 DRUG-RESISTANT GONORRHEA Across all U.S. clinicalAzithromycin settings, dataCiprofloxacin suggest cliniciansCefixime treated Penicillin Ceftriaxone Tetracycline Many people who have gonorrhea may not have most patients with CDC’s recommended gonorrhea treatment symptoms, so timely diagnosis through routine in 2017. screening, with prompt and effective treatment, is needed. CDC develops evidence-based STD Treatment STD Clinic Guidelines, which are the cornerstone of STD prevention and control. It is essential for healthcare providers Private Provider to follow the guidance to treat their patients with the correct antibiotic, which also slows the threat of Emergency Room emerging antibiotic resistance and helps to reduce gonorrhea in the United States. Family Planning A recent CDC analysis found that healthcare providers Other Health treated most patients with gonorrhea (82%) in 2017 Department Clinic using CDC’s recommended regimen, just two years after All Other CDC published the updated guidelines in 2015. Through the efforts of CDC, partners, and healthcare providers, Unknown/ the uptake of gonorrhea guideline changes by providers Missing Provider was impressively swift. These data highlight the value of 0% 20% 40% 60% 80% 100% robust partnerships to ensure that patients receive the Percent of Patients highest quality STD care. ONLINE RESOURCES About Gonorrhea www.cdc.gov/STD/Gonorrhea/Default.htm Battling Antibiotic-resistant Gonorrhea: A Timeline of Coordinated Teamwork www.cdc.gov/STD/Products/Success/Hawaii-Success-Stories.pdf This fact sheet is part of CDC’s 2019 Antibiotic Resistance Threats Report. The full report, including data sources, is available at www.cdc.gov/DrugResistance/Biggest-Threats.html. CS298822-A.
Load more

Recommended publications
  • Official Nh Dhhs Health Alert
    THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network [email protected] May 18, 2018, 1300 EDT (1:00 PM EDT) NH-HAN 20180518 Tickborne Diseases in New Hampshire Key Points and Recommendations: 1. Blacklegged ticks transmit at least five different infections in New Hampshire (NH): Lyme disease, Anaplasma, Babesia, Powassan virus, and Borrelia miyamotoi. 2. NH has one of the highest rates of Lyme disease in the nation, and 50-60% of blacklegged ticks sampled from across NH have been found to be infected with Borrelia burgdorferi, the bacterium that causes Lyme disease. 3. NH has experienced a significant increase in human cases of anaplasmosis, with cases more than doubling from 2016 to 2017. The reason for the increase is unknown at this time. 4. The number of new cases of babesiosis also increased in 2017; because Babesia can be transmitted through blood transfusions in addition to tick bites, providers should ask patients with suspected babesiosis whether they have donated blood or received a blood transfusion. 5. Powassan is a newer tickborne disease which has been identified in three NH residents during past seasons in 2013, 2016 and 2017. While uncommon, Powassan can cause a debilitating neurological illness, so providers should maintain an index of suspicion for patients presenting with an unexplained meningoencephalitis. 6. Borrelia miyamotoi infection usually presents with a nonspecific febrile illness similar to other tickborne diseases like anaplasmosis, and has recently been identified in one NH resident. Tests for Lyme disease do not reliably detect Borrelia miyamotoi, so providers should consider specific testing for Borrelia miyamotoi (see Attachment 1) and other pathogens if testing for Lyme disease is negative but a tickborne disease is still suspected.
    [Show full text]
  • Avoidance of Mechanisms of Innate Immune Response by Neisseria Gonorrhoeae
    ADVANCEMENTS OF MICROBIOLOGY – POSTĘPY MIKROBIOLOGII 2019, 58, 4, 367–373 DOI: 10.21307/PM–2019.58.4.367 AVOIDANCE OF MECHANISMS OF INNATE IMMUNE RESPONSE BY NEISSERIA GONORRHOEAE Jagoda Płaczkiewicz* Department of Virology, Institute of Microbiology, Faculty of Biology, University of Warsaw Submitted in July, accepted in October 2019 Abstract: Neisseria gonorrhoeae (gonococcus) is a Gram-negative bacteria and an etiological agent of the sexually transmitted disease – gonorrhea. N. gonorrhoeae possesses many mechanism to evade the innate immune response of the human host. Most are related to serum resistance and avoidance of complement killing. However the clinical symptoms of gonorrhea are correlated with a significant pres- ence of neutrophils, whose response is also insufficient and modulated by gonococci. 1. Introduction. 2. Adherence ability. 3. Serum resistance and complement system. 4. Neutrophils. 4.1. Phagocytosis. 4.1.1. Oxygen- dependent intracellular killing. 4.1.2. Oxygen-independent intracellular killing. 4.2. Neutrophil extracellular traps. 4.3. Degranulation. 4.4. Apoptosis. 5. Summary UNIKANIE MECHANIZMÓW WRODZONEJ ODPOWIEDZI IMMUNOLOGICZNEJ PRZEZ NEISSERIA GONORRHOEAE Streszczenie: Neisseria gonorrhoeae (gonokok) to Gram-ujemna dwoinka będąca czynnikiem etiologicznym choroby przenoszonej drogą płciową – rzeżączki. N. gonorrhoeae posiada liczne mechanizmy umożliwiające jej unikanie wrodzonej odpowiedzi immunologicznej gospodarza. Większość z nich związana jest ze zdolnością gonokoków do manipulowania układem dopełniacza gospodarza oraz odpor- nością tej bakterii na surowicę. Jednakże symptomy infekcji N. gonorrhoeae wynikają między innymi z obecności licznych neutrofili, których aktywność jest modulowana przez gonokoki. 1. Wprowadzenie. 2. Zdolność adherencji. 3. Surowica i układ dopełniacza. 4. Neutrofile. 4.1. Fagocytoza. 4.1.1. Wewnątrzkomórkowe zabijanie zależne od tlenu. 4.1.2.
    [Show full text]
  • 3- Chlamydia, Syphilis & Gonorrhea (STD)
    3- Chlamydia, syphilis & gonorrhea (STD) Microbiology 435’s Teamwork Reproductive Block Learning Objectives: ● Know the causative agents of syphilis, gonorrhea and Chlamydia infections. ● Realize that these three infections are acquired through sexual intercourse. ● Know the pathogenesis of syphilis, gonorrhea and Chlamydia infection. ● Describe the clinical feature of the primary, secondary tertiary syphilis and complications. ● Recall the different diagnostic methods for the different stages of syphilis. ● Describe the clinical features of gonorrhea that affect only men, only women and those ones which affect both sexes. ● Describe the different laboratory tests for the diagnosis of gonorrhea ● Describe the morphology and the distinct life cycle of the Chlamydia. ● Realize what are the different genera, species and serotypes of the family Chlamydophila. ● Recognize that Chlamydia cause different diseases that affect the eye (causing trachoma) and the respiratory system (mainly cause a typical pneumonia). ● Know the different urogenital clinical syndromes caused by Chlamydia trachomatis that affect men, women and both sex. ● Realize that these urogenital syndromes are difficult to differentiate clinically from the similar ones caused by N.gonorrheae. ● Know the treatment of syphilis, gonorrhea and Chlamydia infections. ● Realize that there are no effective vaccines against all these three diseases. Important Resources: 435 females & males slides and ​ ​ ​ Males notes notes, wikipedia, ​ ​ Females notes Lippincott’s Illustrated Reviews: Microbiology- ​ ​ Extra Third Edition ​ ​ Editing file: Here ​ ​ Credit: Team members ​ Introduction (take-home message) ● Syphilis, Chlamydia and Gonorrhea are main STDs, caused by delicate organisms that cannot survive ​ ​ ​ outside the body. Infection may not be localized. ​ ​ ● Clinical presentation may be similar (urethral or genital discharge, ulcers). ● One or more organisms (Bacteria, virus, parasite) may be transmitted by sexual contact.
    [Show full text]
  • Molecular Characterization of the Burkholderia Cenocepacia Dcw Operon and Ftsz Interactors As New Targets for Novel Antimicrobial Design
    antibiotics Article Molecular Characterization of the Burkholderia cenocepacia dcw Operon and FtsZ Interactors as New Targets for Novel Antimicrobial Design Gabriele Trespidi y , Viola Camilla Scoffone y, Giulia Barbieri , Giovanna Riccardi, Edda De Rossi * and Silvia Buroni * Department of Biology and Biotechnology “Lazzaro Spallanzani”, University of Pavia, 27100 Pavia, Italy; [email protected] (G.T.); viola.scoff[email protected] (V.C.S.); [email protected] (G.B.); [email protected] (G.R.) * Correspondence: [email protected] (E.D.R.); [email protected] (S.B.) These authors contributed equally to this work. y Received: 20 October 2020; Accepted: 23 November 2020; Published: 24 November 2020 Abstract: The worldwide spread of antimicrobial resistance highlights the need of new druggable cellular targets. The increasing knowledge of bacterial cell division suggested the potentiality of this pathway as a pool of alternative drug targets, mainly based on the essentiality of these proteins, as well as on the divergence from their eukaryotic counterparts. People suffering from cystic fibrosis are particularly challenged by the lack of antibiotic alternatives. Among the opportunistic pathogens that colonize the lungs of these patients, Burkholderia cenocepacia is a well-known multi-drug resistant bacterium, particularly difficult to treat. Here we describe the organization of its division cell wall (dcw) cluster: we found that 15 genes of the dcw operon can be transcribed as a polycistronic mRNA from mraZ to ftsZ and that its transcription is under the control of a strong promoter regulated by MraZ. B. cenocepacia J2315 FtsZ was also shown to interact with the other components of the divisome machinery, with a few differences respect to other bacteria, such as the direct interaction with FtsQ.
    [Show full text]
  • Gonorrhea, Chlamydia, and Syphilis
    2019 GONORRHEA, CHLAMYDIA, AND SYPHILIS AND CHLAMYDIA, GONORRHEA, Dedication TAG would like to thank the National Coalition of STD Directors for funding and input on the report. THE PIPELINE REPORT Pipeline for Gonorrhea, Chlamydia, and Syphilis By Jeremiah Johnson Introduction The current toolbox for addressing gonorrhea, chlamydia, and syphilis is inadequate. At a time where all three epidemics are dramatically expanding in locations all around the globe, including record-breaking rates of new infections in the United States, stakeholders must make do with old tools, inadequate systems for addressing sexual health, and a sparse research pipeline of new treatment, prevention, and diagnostic options. Lack of investment in sexual health research has left the field with inadequate prevention options, and limited access to infrastructure for testing and treatment have allowed sexually transmitted infections (STIs) to flourish. The consequences of this underinvestment are large: according to the World Health Organization (WHO), in 2012 there were an estimated 357 million new infections (roughly 1 million per day) of the four curable STIs: gonorrhea, chlamydia, syphilis, and trichomoniasis.1 In the United States, the three reportable STIs that are the focus of this report—gonorrhea, chlamydia, and syphilis—are growing at record paces. In 2017, a total of 30,644 cases of primary and secondary (P&S) syphilis—the most infectious stages of the disease—were reported in the United States. Since reaching a historic low in 2000 and 2001, the rate of P&S syphilis has increased almost every year, increasing 10.5% during 2016–2017. Also in 2017, 555,608 cases of gonorrhea were reported to the U.S.
    [Show full text]
  • Disease Control Newsletter Is Available on the MDH IDCN Web Site: (
    ISEASE ONTROL EWSLETTER DVolume 46, Number 1 (pages 1-30) C N 2019 Annual Summary of Communicable Diseases Reported to the Minnesota Department of Health, 2018 Introduction Anaplasmosis Assessment of the population’s health is a core public health function. Anaplasmosis, caused by Anaplasma Surveillance for communicable diseases is one type of assessment. Epidemiologic phagocytophilum, is transmitted surveillance is the systematic collection, analysis, and dissemination of health by bites from Ixodes scapularis, data for the planning, implementation, and evaluation of health programs. the blacklegged tick. Although the The Minnesota Department of Health (MDH) collects information on infectious organism that causes anaplasmosis diseases for the purposes of determining disease impact, assessing trends in was previously known by other disease occurrence, characterizing affected populations, prioritizing control names and thought to be a part of efforts, and evaluating prevention strategies. Prompt reporting allows outbreaks the genus Ehrlichia, anaplasmosis and to be recognized in a timely fashion when control measures are most likely to be ehrlichiosis (due to E. chaffeensis) are effective in preventing additional cases. distinct diseases caused by different rickettsial species. The same tick vector In Minnesota, communicable disease reporting is centralized, whereby reporting also transmits the etiologic agents of sources submit standardized reports to MDH. Cases of disease are reported Lyme disease, babesiosis, ehrlichiosis pursuant to Minnesota Rules Governing Communicable Diseases (Minnesota (due to E. muris), and Powassan Rules 4605.7000 -4605.7800). The diseases listed in Table 1 must be reported virus. In rare circumstances, A. to MDH. As stated in the rules, physicians, health care facilities, laboratories, phagocytophilum may be transmitted veterinarians, and others are required to report these diseases.
    [Show full text]
  • Chlamydia, Gonorrhoea, Trichomoniasis and Syphilis
    Research Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016 Jane Rowley,a Stephen Vander Hoorn,b Eline Korenromp,c Nicola Low,d Magnus Unemo,e Laith J Abu- Raddad,f R Matthew Chico,g Alex Smolak,f Lori Newman,h Sami Gottlieb,a Soe Soe Thwin,a Nathalie Brouteta & Melanie M Taylora Objective To generate estimates of the global prevalence and incidence of urogenital infection with chlamydia, gonorrhoea, trichomoniasis and syphilis in women and men, aged 15–49 years, in 2016. Methods For chlamydia, gonorrhoea and trichomoniasis, we systematically searched for studies conducted between 2009 and 2016 reporting prevalence. We also consulted regional experts. To generate estimates, we used Bayesian meta-analysis. For syphilis, we aggregated the national estimates generated by using Spectrum-STI. Findings For chlamydia, gonorrhoea and/or trichomoniasis, 130 studies were eligible. For syphilis, the Spectrum-STI database contained 978 data points for the same period. The 2016 global prevalence estimates in women were: chlamydia 3.8% (95% uncertainty interval, UI: 3.3–4.5); gonorrhoea 0.9% (95% UI: 0.7–1.1); trichomoniasis 5.3% (95% UI:4.0–7.2); and syphilis 0.5% (95% UI: 0.4–0.6). In men prevalence estimates were: chlamydia 2.7% (95% UI: 1.9–3.7); gonorrhoea 0.7% (95% UI: 0.5–1.1); trichomoniasis 0.6% (95% UI: 0.4–0.9); and syphilis 0.5% (95% UI: 0.4–0.6). Total estimated incident cases were 376.4 million: 127.2 million (95% UI: 95.1–165.9 million) chlamydia cases; 86.9 million (95% UI: 58.6–123.4 million) gonorrhoea cases; 156.0 million (95% UI: 103.4–231.2 million) trichomoniasis cases; and 6.3 million (95% UI: 5.5–7.1 million) syphilis cases.
    [Show full text]
  • Response of Gonococcal Clinical Isolates to Acidic Conditions
    J. Med. Microbiol. - Vol. 48 (1999), 149-156 0 1999 The Pathological Society of Great Britain and Ireland BACTERIAL PATHOGEN IClTY Response of gonococcal clinical isolates to acidic conditions R. K. PETTIT, S. C. McALLISTER* and TRACI A. HAMER* Cancer Research Institute and Department of Microbiology, Arizona State University, Tempe, AZ 85287- 1604 and * Department of Biology, Western Oregon University, Monmouth, Oregon 9736 I, USA This study examined the response to acidic conditions of four gonococcal isolates - NU38874 (Proto/IB-2), NRL38884 (Pro/IA-2), NRL38953 (Proto/IB-3) and NRL39029 (Pro/IA-3) - obtained from various sites in patients in whom a diagnosis of pelvic inflammatory disease had been made by laparoscopic examination. Acid tolerance of the clinical isolates was strain and growth phase dependent. Growth of the four strains on solid media was undetectable below pH 5.8. In liquid culture, strain NRL38884 did not survive below pH 5.2; strains NRL38874, NRL38953 and NRL39029 survived to pH 4.5. Between pH 4.2 and pH 5.1, the latter three strains exhibited a peak in survival at pH 4.6-4.7 during log phase, suggesting that there may be a distinct acid tolerance system operating at this pH. SDS-PAGE of whole-cell, total membrane and outer-membrane fractions of the four strains prepared from pH 7.2 and pH 6.1 plate cultures revealed numerous differences in protein composition. Acidic conditions reduced the expression of the reduction modifiable outer-membrane protein Rmp, and induced the expression of many membrane proteins, including gonococcal hsp63. Immunoblotting studies with matched serum samples and strains from patients with pelvic inflammatory disease indicated that IgG recognition of outer-membrane components from strains cultured in acidic and neutral conditions was quite different.
    [Show full text]
  • Aerobactin Utilization by Neisseria Gonorrhoeae and Cloning of a Genomic DNA Fragment That Complements Escherichia Coli Fhub Mutations SUSAN E
    JOURNAL OF BACTERIOLOGY, Aug. 1987, p. 3414-3421 Vol. 169, No. 8 0021-9193/87/083414-08$02.00/0 Copyright © 1987, American Society for Microbiology Aerobactin Utilization by Neisseria gonorrhoeae and Cloning of a Genomic DNA Fragment That Complements Escherichia coli fhuB Mutations SUSAN E. H. WESTt* AND P. FREDERICK SPARLING Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27514 Received 17 February 1987/Accepted 28 April 1987 Aerobactin, a dihydroxamate siderophore produced by many strains of enteric bacteria, stimulated the growth of Neisseria gonorrhoeae FA19 and F62 in iron-limiting medium. However, gonococci did not produce detectable amounts of aerobactin in the Escherichia coli LG1522 aerobactin bioassay. We probed gonococcal genomic DNA with the cloned E. coli aerobactin biosynthesis (iucABCD), aerobactin receptor (iutA), and hydroxamate utilization (flwCDB) genes. Hybridization was detected with IhuB sequences but not with the other genes under conditions which will detect 70% or greater homology. Similar results were obtained with 21 additional strains of gonococci by colony filter hybridization. A library of DNA from N. gonorrhoeae FA19 was constructed in the ph id vector XSE4, and a clone was isolated that complemented theihuB mutation in derivatives ofE. coli BU736 and BN3307. These results suggest thatfJhuB is a conserved gene and may play a fundamental role in iron acquisition by N. gonorrhoeae. Most microbial iron acquisition systems consist of two product is apparently a very hydrophobic membrane protein components: a siderophore which is a soluble low-molecu- of 70,337 Mr as calculated from the nucleotide sequence (23); lar-weight iron-chelating compound and a specific cell sur- its exact location in the membranes of E.
    [Show full text]
  • CHAPTER 4 Infectious Disease
    CHAPTER 4 Infectious Disease 99 | Massachusetts State Health Assessment Infectious Disease This chapter provides information on preventing and controlling infectious diseases, and related trends, disparities, and resources in the Commonwealth of Massachusetts. It addresses the following infectious disease topic areas: • Foodborne Diseases • Healthcare-Associated Infections • Sexually Transmitted Infections • Human Immunodeficiency Virus • Viral Hepatitis • Tuberculosis • Vectorborne Diseases • Immunization • Selected Resources, Services, and Programs Chapter Data Highlights • Over 4,200 confirmed cases of foodborne disease in 2015 • HIV infections decreased by 31% from 2005 to 2014 • In 2015, hepatitis C case rates were 26 and 10 times higher, respectively, among White non-Hispanics compared to Asian non-Hispanics and Black non-Hispanics • In 2016, 190 cases of TB were reported in Massachusetts • Tickborne babesiosis increased 15% from 2015 to 2016 • Influenza and pneumonia ranked in the top ten leading causes of death among Massachusetts residents in 2014 100 | Massachusetts State Health Assessment Overview Infectious diseases have been causing human illness and death since the dawn of human existence. The effective prevention and control of these diseases is one of the major reasons for increases in life expectancy. In 1701, Massachusetts passed legislation requiring the isolation of the sick “for better preventing the spread of infection.”190 Since then, Massachusetts has led the nation in infection prevention and control. For example, Massachusetts was the only state to achieve a score of 10 out of 10 in Health Security Ranking which includes reducing healthcare-associated infections (HAIs), biosafety training in public health laboratories, public health funding commitment, national health security preparedness, public health accreditation, flu vaccination rates, climate change readiness,afety as well as a biosafety professional on staff and emergency health care access.
    [Show full text]
  • Atypical, Yet Not Infrequent, Infections with Neisseria Species
    pathogens Review Atypical, Yet Not Infrequent, Infections with Neisseria Species Maria Victoria Humbert * and Myron Christodoulides Molecular Microbiology, School of Clinical and Experimental Sciences, University of Southampton, Faculty of Medicine, Southampton General Hospital, Southampton SO16 6YD, UK; [email protected] * Correspondence: [email protected] Received: 11 November 2019; Accepted: 18 December 2019; Published: 20 December 2019 Abstract: Neisseria species are extremely well-adapted to their mammalian hosts and they display unique phenotypes that account for their ability to thrive within niche-specific conditions. The closely related species N. gonorrhoeae and N. meningitidis are the only two species of the genus recognized as strict human pathogens, causing the sexually transmitted disease gonorrhea and meningitis and sepsis, respectively. Gonococci colonize the mucosal epithelium of the male urethra and female endo/ectocervix, whereas meningococci colonize the mucosal epithelium of the human nasopharynx. The pathophysiological host responses to gonococcal and meningococcal infection are distinct. However, medical evidence dating back to the early 1900s demonstrates that these two species can cross-colonize anatomical niches, with patients often presenting with clinically-indistinguishable infections. The remaining Neisseria species are not commonly associated with disease and are considered as commensals within the normal microbiota of the human and animal nasopharynx. Nonetheless, clinical case reports suggest that they can behave as opportunistic pathogens. In this review, we describe the diversity of the genus Neisseria in the clinical context and raise the attention of microbiologists and clinicians for more cautious approaches in the diagnosis and treatment of the many pathologies these species may cause. Keywords: Neisseria species; Neisseria meningitidis; Neisseria gonorrhoeae; commensal; pathogenesis; host adaptation 1.
    [Show full text]
  • Sexually Transmitted Neisseria Gonorrhoeae Infections—Update On
    medicines Review Sexually Transmitted Neisseria gonorrhoeae Infections— Update on Drug Treatment and Vaccine Development Amber Jefferson 1, Amanda Smith 1, Pius S. Fasinu 2 and Dorothea K. Thompson 2,* 1 School of Pharmacy, College of Pharmacy & Health Sciences, Campbell University, Buies Creek, NC 27506, USA; [email protected] (A.J.); [email protected] (A.S.) 2 Department of Pharmaceutical Sciences, College of Pharmacy & Health Sciences, Campbell University, Buies Creek, NC 27506, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-910-893-7463 Abstract: Background: Sexually transmitted gonorrhea, caused by the Gram-negative diplococcus Neisseria gonorrhoeae, continues to be a serious global health challenge despite efforts to eradicate it. Multidrug resistance among clinical N. gonorrhoeae isolates has limited treatment options, and attempts to develop vaccines have not been successful. Methods: A search of published literature was conducted, and information extracted to provide an update on the status of therapeutics and vaccine development for gonorrheal infection. Results: Recommended pharmacological treatment for gonorrhea has changed multiple times due to increasing acquisition of resistance to existing antibiotics by N. gonorrhoeae. Only broad-spectrum cephalosporin-based combination therapies are currently recommended for treatment of uncomplicated urogenital and anorectal gonococcal infections. With the reported emergence of ceftriaxone resistance, successful strategies addressing the global burden of gonorrhea must include vaccination. Century-old efforts at developing an effective vaccine against gonorrhea, leading to only four clinical trials, have not yielded any successful vaccine. Citation: Jefferson, A.; Smith, A.; Conclusions: While it is important to continue to explore new drugs for the treatment of gonorrhea, Fasinu, P.S.; Thompson, D.K.
    [Show full text]